Skip to main content
. Author manuscript; available in PMC: 2019 Feb 25.
Published in final edited form as: Am J Prev Med. 2018 Oct 22;55(6):777–786. doi: 10.1016/j.amepre.2018.07.005

Table 2.

Secondary Outcomes

Variable Intervention Usual care Between-groups difference, Adjusted mean difference (95% CI) p-value
N Adjusted mean change (95% CI) from baseline N Adjusted mean change (95% CI) from baseline
BMI
 6 months 170 −1.4 (−1.7, −1.1) 167 0.2 (−0.07, 0.5) −1.6 (−2.0, −1.2) <0.0001
 12 months 170 −1.4 (−1.7, −1.0) 167 −0.01 (−0.3, 0.3) −1.4 (−1.8, −0.9) <0.0001
Waist circumference, cm
 6 months 170 −3.4 (−4.3, −2.4) 167 0.1 (−0.8, 1.1) −3.5 (−4.8, −2.2) <0.0001
 12 months 170 −2.9 (−4.0, −1.9) 167 0.6 (−0.4, 1.6) −3.6 (−5.0, −2.1) <0.0001
SBP, mm Hg
 6 months 170 −4.6 (−7.5, −1.7) 167 −3.4 (−6.3, −0.6) −1.2 (−5.0, 2.6) 0.54
 12 months 170 −8.4 (−11.4, −5.3) 167 −7.5 (−10.4, −4.5) −0.9 (−4.9, 3.1) 0.65
DBP, mm Hg
 6 months 170 −4.1 (−5.9, −2.4) 167 −2.5 (−4.2, −0.8) −1.6 (−3.9, 0.7) 0.16
 12 months 170 −5.2 (−7.1, −3.3) 167 −4.2 (−6.1, −2.4) −1.0 (−3.5, 1.5) 0.43
Total cholesterol, mg/dL
 12 months 136 −3.5 (−10.5, 3.5) 149 −6.6 (−13.2, 0.1) 3.1 (−4.7, 10.9) 0.44
LDL, mg/dL
 12 months 119 −5.0 (−11.8,1.7) 133 −1.8 (−8.3, 4.6) −3.2 (−10.5, 4.1) 0.39
HDL, mg/dL
 12 months 133 3.2 (1.0, 5.3) 148 −0.3 (−2.3, 1.7) 3.5 (1.1, 5.9) 0.005
Triglycerides, mg/dL
 12 months 129 −6.4 (−25.1, 12.3) 143 −13.2 (−30.6, 4.2) 6.8 (−14.0, 27.6) 0.52
Glucose, mg/dL
 12 months 136 −4.9 (−13.0, 3.2) 151 3.2 (−4.4, 10.9) −8.1 (−17.1, 0.9) 0.08
HbA1c, %
 12 months 129 −0.3 (−0.5, −0.2) 146 −0.2 (−0.04, −0.001) −0.2 (−0.4, 0.04) 0.11

Note: SI conversion factors: To convert cholesterol to mmol/L, multiply values by 0.0259; triglycerides to mmol/L, multiply values by 0.0113; fasting glucose to mmol/L, multiply values by 0.0555.

DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure.